Skip to content
‹ Back to IndustriesSciences

Where Will the Money Come from in Space Sustainability?

On the Space to Grow podcast, Astroscale's Chris Blackerby and Charity Weeden interview CEO and founder Nobu Okada to explore the commercial, policy, and technological dimensions of space sustainability. The conversation addresses where funding will come from to support responsible space operations, debris removal, and long-term orbital stewardship.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Chris Blackerby · · AstroscaleCharity WeedenChris BlackerbyFunding
Share

Key takeaways

01

Identifying viable commercial and governmental funding models for space sustainability initiatives.

02

International policy frameworks are critical to enabling scalable, responsible space operations.

03

Astroscale's leadership discusses the technology roadmap and business case for satellite servicing and debris removal.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

On the Space to Grow podcast, Astroscale’s Chris Blackerby and Charity Weeden bring their compelling experience and expertise to map out the technology, international policy, and scalability that will define the next generation of space exploration.

Space to Grow has an exciting episode featuring Astroscale CEO and Founder Nobu Okada. In this interview, Chris Blackerby and Charity Weeden talk to their boss and the man behind bringing awareness and industry to the space sustainability market.

Okada’s career didn’t begin in space, although space was certainly mesmerizing to him early. He traveled to the U.S. to attend Space Camp as a teen, something Weeden did, as well. The love story with space wouldn’t be a major part of his life for years. His career included work in Japan’s Ministry of Finance, as a consultant with McKinsey, and leading IT startups.

“The commercial role of space sustainability is coming, with awareness raised in the past few years” – Nobu Okada

Okada said starting Astroscale was a journey to do something different. He was looking for hot topics in space and found sustainability. He attended a global conference in April of 2013.

“No one had solutions or were taking any actions to clean up space.” So, he decided to hold that torch, founding Astroscale a week later. Since then, he’s raised over $191 million.

Raising money for any business is challenging, for space-related startups, maybe even more so because it’s not a quick return. Okada said, “Investors are simple and focused on ROI. The rules are making them feel secure, confident, and happy. We also carefully designed the terms and conditions for each series.”

Okada admits the very first series was a leap of faith for investors. “We had big passion, people, and no technology. At that point, people are investing in you.”

Since then, the company has proved the market is there. Still, it’s a slow process to transform space into a sector where commercialization is a bigger part of the picture. Now, the biggest customer for space-related solutions is government. Okada believes a turning point is coming. “We have to create the future, not wait for it. The commercial role of space sustainability is coming, with awareness raised in the past few years,” he noted.

Listen to Previous Episodes Here!

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

CB
Chris Blackerby
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Why shared auto-injectors keep forcing rebuilt device files

Why shared auto-injectors keep forcing rebuilt device files

Vertex Knight co-founder Fubin Wu names digitalization, personalization and large-volume delivery as the trends reshaping drug delivery devices, arguing structured data can end rebuilding design files for shared auto-injectors. ISPE says no regulatory pathway exists for platform devices, and ONdrugDelivery counts 182 large-volume subcutaneous biologics, about 15% of the injectable pipeline.

  • 01A device shared across drug products still triggers repeated design control work for each new combination product, and ISPE's November 2025 article says no regulatory pathway yet exists to approve a platform device.
  • 02FDA's May 2024 draft platform technology designation under section 506K is written for drug product applications, so device design files sit outside it.
  • 03Large-volume subcutaneous biologics above 2 mL numbered 182 in a January 2025 ONdrugDelivery review, about 15% of IV and SC agents; Advanced Drug Delivery Reviews reported in July 2026 that volumes up to 25 mL are now pursued.

Oct 22, 2026

Hepalink's FOYA-winning syringe plant inspects 24,000 units an hour

Hepalink's FOYA-winning syringe plant inspects 24,000 units an hour

Hepalink's Pingshan prefilled syringe plant in Shenzhen won the Innovation (Novel Technology) category at ISPE's 2026 Facility of the Year Awards. In the transcript ISPE posted with its podcast, CaiXue Wei describes vertical design, AGV-assisted transfer, AI inspection and 5G-MEC as one integrated system built around a 330 million-syringe annual capacity; Hepalink's own release adds a 24-meter warehouse, sub-10 millisecond 5G and 24,000-unit-an-hour inspection.

  • 01Hepalink's 24-meter automated warehouse raised space utilization 52 percent over a traditional layout on a land-scarce Shenzhen site supporting 330 million syringes a year.
  • 02AGVs pass material through vaporized hydrogen peroxide chambers straight into Grade A isolators, and Hepalink credits the zero-touch flow for a 100 percent first media fill.

Oct 22, 2026

Chalmers' AI scientist turned 60,000 yeast records into nearly 2,000 testable ideas

Chalmers' AI scientist turned 60,000 yeast records into nearly 2,000 testable ideas

Chalmers University of Technology's AI scientist Eve analyzed about 60,000 public yeast records, came up with almost 2,000 testable ideas, and took full charge of planning the experiments and telling other robots what to do, according to CORDIS. Humans handled safety checks and plate moving.

  • 01The key step for company labs is translation: turning hypotheses into machine-executable protocols and getting contextualized results back to the reasoning layer fast.

Oct 19, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Experts

CB
Chris Blackerby

COO, Astroscale

Chris Blackerby is Chief Operating Officer at Astroscale, a company focused on satellite servicing and the long-term sustainable development of space. He has a background in space policy and international affairs, including prior roles at NASA. He co-hosts the Space to Grow podcast alongside Charity Weeden.

CW
Charity Weeden

VP, Global Space Policy

Astroscale

Charity Weeden serves as Vice President of Global Space Policy at Astroscale, where she focuses on international regulatory and policy frameworks for space sustainability. She co-hosts the Space to Grow podcast with Chris Blackerby.

NO
Nobu Okada

CEO and Founder

Astroscale

Nobu Okada is the Founder and CEO of Astroscale, which he established in 2013 with a mission to secure the safe and sustainable development of space for future generations. Under his leadership, Astroscale has become a leading commercial provider of satellite servicing and debris removal solutions.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512